IMUX (Immunic, Inc.) Stock Financials & Earnings | Market Cap Arena

IMUXImmunic, Inc.

Mkt Cap$135M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$97M

EPS (TTM)-$0.62

Free Cash Flow (TTM)-$86M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$27M
Q2 23	$0	$0	-$25M
Q3 23	$0	$0	-$24M
Q4 23	$0	-$23K	-$23M
Q1 24	$0	-$26K	-$24M
Q2 24	$0	-$31K	-$23M
Q3 24	$0	$0	-$26M
Q4 24	$0	-$35K	-$26M
Q1 25	$0	$0	-$27M
Q2 25	$0	$0	-$27M
Q3 25	$0	$0	-$26M
Q4 25	$0	-$42K	-$23M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$20M	-$20M
Q2 23	-$20M	-$20M
Q3 23	-$17M	-$17M
Q4 23	-$14M	-$14M
Q1 24	-$24M	-$24M
Q2 24	-$17M	-$17M
Q3 24	-$21M	-$21M
Q4 24	-$23M	-$23M
Q1 25	-$22M	-$22M
Q2 25	-$25M	-$25M
Q3 25	-$20M	-$20M
Q4 25	-$19M	-$19M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$104K
Q2 23	$21K
Q3 23	$44K
Q4 23	$165K
Q1 24	$31K
Q2 24	$180K
Q3 24	$50K
Q4 24	$3K
Q1 25	$47K
Q2 25	$36K
Q3 25	$67K
Q4 25	$11K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	+27.1%
Q2 23	—	+21.4%
Q3 23	—	+17.2%
Q4 23	—	-59.2%
Q1 24	—	-12.4%
Q2 24	—	-8.8%
Q3 24	—	+9.1%
Q4 24	—	+9.6%
Q1 25	—	+12.3%
Q2 25	—	+18.7%
Q3 25	—	+1.0%
Q4 25	—	-9.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$2M	—
Q2 23	$2M	—
Q3 23	$2M	—
Q4 23	$2M	—
Q1 24	$3M	—
Q2 24	$2M	—
Q3 24	$2M	—
Q4 24	$2M	—
Q1 25	$2M	—
Q2 25	$2M	—
Q3 25	$4M	—
Q4 25	$1M	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$23M	$4M	—
Q2 23	$21M	$4M	—
Q3 23	$20M	$4M	—
Q4 23	$19M	$4M	—
Q1 24	$19M	$5M	—
Q2 24	$18M	$4M	—
Q3 24	$21M	$4M	—
Q4 24	$22M	—	$4M
Q1 25	$22M	$5M	—
Q2 25	$21M	$6M	—
Q3 25	$20M	—	$6M
Q4 25	$19M	$10M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$93M	$4M	$97M
Q2 23	$77M	$0	$77M
Q3 23	$60M	$0	$60M
Q4 23	$47M	$0	$47M
Q1 24	$97M	$0	$97M
Q2 24	$80M	$0	$80M
Q3 24	$59M	$0	$59M
Q4 24	$36M	$0	$36M
Q1 25	$14M	$0	$14M
Q2 25	$55M	$0	$55M
Q3 25	$35M	$0	$35M
Q4 25	$15M	$0	$15M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	44M	+37.2%
Q2 23	44M	+1.8%
Q3 23	45M	+0.3%
Q4 23	45M	+0.1%
Q1 24	97M	+118.0%
Q2 24	101M	+4.1%
Q3 24	101M	+0.0%
Q4 24	90M	-11.0%
Q1 25	101M	+12.4%
Q2 25	132M	+30.4%
Q3 25	194M	+46.7%
Q4 25	1.56B	+702.9%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$0	96
FY 15	$0	78
FY 16	$73	87
FY 17	$0	97
FY 18	$0	10
FY 19	$0	26
FY 20	$0	28
FY 21	$0	55
FY 22	$0	66
FY 23	$0	77
FY 24	$0	91
FY 25	$0	92

IMUX (Immunic, Inc.) Stock Financials & Earnings | Market Cap Arena